Clonal Haematopoiesis Tracks Alzheimer's-like Cortical Atrophy in Community-Dwelling Older Adults
This study demonstrates that clonal haematopoiesis burden in cognitively healthy older adults is longitudinally associated with progressive, Alzheimer's-like cortical atrophy, suggesting it may serve as a marker for adverse brain ageing.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
As people age, their bodies undergo a quiet, internal reshuffling. In the blood, this process is known as clonal haematopoiesis. It begins when a single blood stem cell acquires a genetic change that gives it a slight advantage over its neighbors. This "mutant" cell begins to multiply, eventually forming a large family, or clone, that takes up a significant portion of the blood supply. This phenomenon is common in older adults, appearing in about ten percent of people in their seventies. While scientists have long known that these expanding blood clones are linked to heart disease and blood cancers, their relationship with the aging brain has remained a mystery. Some studies suggested these blood changes might protect the brain, while others hinted they could be harmful. The truth, however, has been difficult to pin down because most previous research relied on a single snapshot of a person's blood and brain, making it impossible to see how changes in one might drive changes in the other over time.
A team of researchers set out to solve this puzzle by looking at the same group of people over several years, tracking both their blood and their brains as they aged. They focused on the Lothian Birth Cohort 1936, a group of nearly 1,100 people living in the Edinburgh area who were born in the same year and have been studied for decades. The researchers had access to blood samples and brain scans taken when these participants were 73, 76, and 79 years old. Instead of looking for specific genetic mutations, which can be missed by standard tests, the team used a new method to estimate the overall "burden" of these blood clones based on chemical markers on the DNA. They then compared these blood measurements to the size and structure of the participants' brains, looking for patterns of shrinkage that might reveal how the blood and brain are connected.
The study revealed a clear and concerning link between the expansion of blood clones and the aging brain. The researchers found that individuals with a higher burden of these blood clones tended to have smaller brains overall. More importantly, they discovered that as the blood clones grew larger over the six-year study period, the brain's grey matter—the tissue responsible for processing information—shrank at a faster rate. This was not a random loss of brain tissue; the shrinkage followed a very specific map. The areas that lost volume most quickly were located in the left side of the brain, particularly in regions involved in memory and spatial awareness, such as the medial temporal and parietal lobes.
What made this finding particularly striking was that the pattern of brain loss closely matched the pattern seen in Alzheimer's disease. The researchers compared their results to a well-known map of brain vulnerability in Alzheimer's patients and found a significant overlap. The regions that were most affected by the blood clones were the same regions that typically suffer in Alzheimer's. However, the story was not a perfect match. While the outer layers of the brain showed this Alzheimer's-like pattern of decline, the deep structures of the brain, such as the hippocampus which is central to memory, did not show the same clear signs of damage. Additionally, the caudate, a structure involved in movement, appeared to be relatively preserved in people with high blood clone burdens, a finding that diverges from the typical profile of Alzheimer's disease.
To ensure these results were robust, the team developed a second, independent way to measure the blood changes, focusing on the broader chemical environment of the blood rather than just the size of the clones. This second measure confirmed that a higher burden of blood changes was linked to a smaller brain overall, but it showed a different pattern of regional decline, suggesting that the two methods might be capturing different aspects of how blood health influences the brain. The researchers also checked their work against potential confounding factors, such as the number of different types of blood cells, and found that the main results held true even after these adjustments.
The study concludes that the expansion of blood clones is a marker of biological aging that tracks with the physical shrinking of the brain, specifically in patterns that resemble Alzheimer's disease. While the findings do not prove that these blood changes cause Alzheimer's, they suggest a strong connection between the health of the blood system and the integrity of the brain. The fact that the brain shrinkage followed a specific, disease-like map, yet spared some key deep structures, indicates that the process might be a form of accelerated aging that shares features with neurodegeneration but is not identical to it. This research opens a new window into understanding how the body's internal systems age together, suggesting that the blood might hold clues to the brain's vulnerability long before symptoms of memory loss appear.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.